Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02490683 · ClinicalTrials.gov registry record · NA
Effects of Soy Based Dietary Supplements on Cardiometabolic Risk Factors.
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02490683 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 24 participants.
The verdict
NCT02490683, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study will test the effect of both Luna Rich X© and Reliv Now© against placebo pills or powder (control) on blood lipids. It will also explore the potential effects of these dietary supplements on inflammation markers and other biological and anthropometric measures. The study intervention will be 30 weeks in length. Twenty four subjects with 2 or more cardiometabolic risk factors will be randomized to participate in the study.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Luna Rich X
- DIETARY_SUPPLEMENT Reliv Now
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-10 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02490683
The ClinicalTrials.gov registry entry for NCT02490683 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02490683 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02490683 about?
NCT02490683 is a clinical study titled "Effects of Soy Based Dietary Supplements on Cardiometabolic Risk Factors.". This study will test the effect of both Luna Rich X© and Reliv Now© against placebo pills or powder (control) on blood lipids. It will also explore the potential effects of these dietary supplements on inflammation markers and other biological and anthropometric measures. The study intervention will...
What is the current status of trial NCT02490683?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2015-10. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02490683?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Luna Rich X (DIETARY_SUPPLEMENT), Reliv Now (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02490683?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.